Lorcaserin and phentermine exert anti-obesity effects with modulation of the gut microbiota
Although drugs have been reported to modulate the gut microbiota, the effects of anti-obesity drugs on the gut microbiota remain unclear. Lorcaserin (LS) and phentermine (PT) are commonly used anti-obesity drugs. However, to our best knowledge, no studies have simultaneously assessed the effects of...
Main Authors: | Eun-Ji Song, Na Rae Shin, Songhee Jeon, Young-Do Nam, Hojun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.1109651/full |
Similar Items
-
Challenging obesity, diabetes, and addiction: the potential of lorcaserin extended release
by: Hurt RT, et al.
Published: (2018-09-01) -
A Narrative Review: Phentermine and Topiramate for the Treatment of Pediatric Obesity
by: Kim A, et al.
Published: (2023-08-01) -
Supraventricular tachycardia associated with phentermine use
by: Pakpoom Tantrachoti, et al.
Published: (2016-07-01) -
Phentermine-Associated Atrial Fibrillation: Case Report and Literature Review
by: Nouraldeen Manasrah, et al.
Published: (2022-03-01) -
Effects of Orlistat/Phentermine versus Phentermine on Vascular Endothelial Cell Function in Obese and Overweight Adults: A Randomized, Double-Blinded, Placebo-Controlled Trial
by: Kwon YJ, et al.
Published: (2021-03-01)